NewLink Genetics
Ames
About NewLink Genetics
NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer. Founded more than 15 years ago, NewLink Genetics continues to be at the forefront in immuno-oncology treatments led by a diverse group of industry professionals and physician-scientists. Personal cancer stories inspire their relentless research and development in advancing treatments. Their mission is to change the cancer treatment paradigm and make a difference in patient lives every day.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Total funding: $33.6M
- Funding stage: M&A
- Last round: Series D (Jul 2009)
- Ticker: nasdaq:NLNK
- Website: newlinkgenetics.com
- Phone: (515) 598-2928
Industries & Categories
Biotechnology, Genetics, Health Care, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/newlink-genetics-1492591 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.